Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL).

Abstract	Five patients, three males and two females, with angioimmunoblastic lymphadenopathy (AIL) are described. The two who received steroids had no response and died 2 and 6 months later. The three patients who received vincristine, adriamycin and prednisolone (VAP) went into remission early and are still in remission with a follow-up of 22-35 months. It is concluded that VAP is effective therapy in AIL.
Authors	A S Awidi, M S Tarawneh, M S Abu Khalaf, M S Al Khateeb, S S Amr
Journal	Cancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 10 Issue 3 Pg. 221-2 ( 1983) ISSN: 0344-5704 [Print] Germany
PMID	6861268 (Publication Type: Journal Article)
Chemical References	Vincristine Doxorubicin Prednisolone
Topics	Adult Antineoplastic Combined Chemotherapy Protocols Doxorubicin (administration & dosage, adverse effects) Drug Therapy, Combination Female Follow-Up Studies Humans Immunoblastic Lymphadenopathy (drug therapy) Male Middle Aged Prednisolone (administration & dosage, adverse effects) Vincristine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!